Evelo Biosciences Inc (EVLO)
0.0005
0.00 (0.00%)
USD |
OTCM |
May 22, 16:00
Evelo Biosciences Total Assets (Quarterly): 20.63M for Sept. 30, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 20.63M |
| June 30, 2023 | 20.82M |
| March 31, 2023 | 41.97M |
| December 31, 2022 | 64.44M |
| September 30, 2022 | 86.34M |
| June 30, 2022 | 111.90M |
| March 31, 2022 | 58.82M |
| December 31, 2021 | 87.87M |
| September 30, 2021 | 116.46M |
| June 30, 2021 | 145.06M |
| March 31, 2021 | 153.04M |
| December 31, 2020 | 90.64M |
| Date | Value |
|---|---|
| September 30, 2020 | 104.84M |
| June 30, 2020 | 113.90M |
| March 31, 2020 | 83.15M |
| December 31, 2019 | 90.92M |
| September 30, 2019 | 111.14M |
| June 30, 2019 | 126.21M |
| March 31, 2019 | 141.93M |
| December 31, 2018 | 159.87M |
| September 30, 2018 | 175.61M |
| June 30, 2018 | 188.29M |
| March 31, 2018 | 122.31M |
| December 31, 2017 | 43.79M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
20.63M
Minimum
Sep 2023
153.04M
Maximum
Mar 2021
90.45M
Average
90.78M
Median
Total Assets (Quarterly) Benchmarks
| Perspective Therapeutics Inc | 278.29M |
| Electromed Inc | 48.90M |
| Xtant Medical Holdings Inc | 93.93M |
| Asensus Surgical Inc | 40.81M |
| Myomo Inc | 16.52M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 47.33M |
| Shareholders Equity (Quarterly) | -26.71M |